[
  {
    "ts": null,
    "headline": "Brown & Brown, Inc. (BRO): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Brown & Brown, Inc. on FluentInquality’s Substack. In this article, we will summarize the bulls’ thesis on BRO. Brown & Brown, Inc.’s share was trading at $ 108.29 as of 19th June. BRO’s trailing and forward P/E ratios were 30.16 and 25.77, respectively, according to Yahoo Finance. Brown & […]",
    "url": "https://finnhub.io/api/news?id=e03de686c31fea626b4990b09e6dc45f58530a6eaa487ed18af7df65a6854340",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750803624,
      "headline": "Brown & Brown, Inc. (BRO): A Bull Case Theory",
      "id": 135513934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BRO",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Brown & Brown, Inc. on FluentInquality’s Substack. In this article, we will summarize the bulls’ thesis on BRO. Brown & Brown, Inc.’s share was trading at $ 108.29 as of 19th June. BRO’s trailing and forward P/E ratios were 30.16 and 25.77, respectively, according to Yahoo Finance. Brown & […]",
      "url": "https://finnhub.io/api/news?id=e03de686c31fea626b4990b09e6dc45f58530a6eaa487ed18af7df65a6854340"
    }
  },
  {
    "ts": null,
    "headline": "Stewart Investors Identifies Six Global Companies Advancing Health Beyond Pharma",
    "summary": "While pharmaceutical drug pricing is making headlines amid President Trump's proposal to benchmark U.S. retail drug costs to international standards, less attention is being paid to attractive, albeit less-glamorous investment areas in the global health ecosystem, according to Stewart Investors, a long-only active global equity specialist.",
    "url": "https://finnhub.io/api/news?id=84f011886825456ecf4e1d3d7a59dcc596c59408c1353449f968589f26c8f12a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750771920,
      "headline": "Stewart Investors Identifies Six Global Companies Advancing Health Beyond Pharma",
      "id": 135497986,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BRO",
      "source": "Yahoo",
      "summary": "While pharmaceutical drug pricing is making headlines amid President Trump's proposal to benchmark U.S. retail drug costs to international standards, less attention is being paid to attractive, albeit less-glamorous investment areas in the global health ecosystem, according to Stewart Investors, a long-only active global equity specialist.",
      "url": "https://finnhub.io/api/news?id=84f011886825456ecf4e1d3d7a59dcc596c59408c1353449f968589f26c8f12a"
    }
  }
]